eli lilly lawsuit tirzepatide update Novo Nordisk filed a against & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Lilly Takes More Legal Actions

Individuals with bleeding disorders or those taking anticoagulation therapy face increased risks from joint injections and should discuss these risks carefully with their healthcare provider

Investing in long-term health and self-care

JT: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing original draft, Writing review and editing

Effects on repetitive 24-hour ambulatory blood pressure in subjects with type II diabetes randomized to liraglutide or glimepiride treatment both in combination with metformin: a randomized open parallel-group study

ongoing monitoring is essential

View published research on PubMed